Failure of carbazochrome sodium sulfonate (AC-17) to prevent dengue vascular permeability or shock: A randomized, controlled trial
- 1 October 1997
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 131 (4) , 525-528
- https://doi.org/10.1016/s0022-3476(97)70055-6
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Dengue virus infection: Epidemiology, pathogenesis, clinical presentation, diagnosis, and preventionThe Journal of Pediatrics, 1997
- Serum Levels of Tumor Necrosis Factor-α (TNF-α), Interleukin-6 (IL-6), and Interleukin-1β (IL-1β) in Dengue-Infected PatientsThe American Journal of Tropical Medicine and Hygiene, 1993
- Dengue haemorrhagic fever and dengue shock syndrome: are they tumour necrosis factor-mediated disorders?FEMS Microbiology Letters, 1991